Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Jetra Therapeutics Logo
Jetra Therapeutics Growth Score
33
CB Rank
136641
Heat Score
80
Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.
Founded
obfuscation
PrivateSeed Brisbane, Queensland, Australia1-10 www.jetratherapeutics.com/
Biotechnology
Manufacturing
Therapeutics
Overview

Jetra Therapeutics
Total Funding
obfuscation
Growth Score
33
Heat Score
80

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score33
-3 pts
in past quarter
Heat Score 80
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Jetra Therapeutics

CB Rank
136641
Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.
Founded
obfuscation
PrivateSeed Brisbane, Queensland, Australia1-10 www.jetratherapeutics.com/
Biotechnology
Manufacturing
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name Jetra Therapeutics Pty Ltd
Operating Status Active
Company Type For Profit
Contact Email info@jetratherapeutics.com
Predictions & Insights

Products & Services

Tissue-targeted IL-22 Protein Therapy
A biologic drug candidate designed to deliver IL-22 cytokine specifically to the liver and pancreas to reduce inflammation and fat accumulation in obesity-related liver diseases such as NASH.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed
obfuscation
Seed Round - Jetra Therapeutics Logo
Seed Round - Jetra Therapeutics
1
obfuscation
IP Group AustraliaSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report
Sub-Organizations
Frequently Asked Questions

Where is Jetra Therapeutics's headquarters? Jetra Therapeutics is located in Brisbane, Queensland, Australia.Who invested in Jetra Therapeutics? Jetra Therapeutics is funded by IP Group Australia.When was the last funding round for Jetra Therapeutics? Jetra Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Jetra Therapeutics's competitors? Alternatives and possible competitors to Jetra Therapeutics may include BioAge Labs, Pfizer, and  Gilead Sciences.How much funding has Jetra Therapeutics raised to date? Jetra Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b944491 1)
|